FDA Slams Dr. Reddy’s Over Fudged Tests, Secret Laboratory
This article was originally published in The Pink Sheet Daily
Executive Summary
In just one of a series of negative events to hit the Indian generics company, FDA warning letter says API for import into US was tested at facility where records didn't include 'initial failing results.'